PortfoliosLab logo

Arcutis Biotherapeutics, Inc. (ARQT)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS03969K1088
CUSIP03969K108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$21.73
Year Range$14.38 - $27.29
EMA (50)$20.29
EMA (200)$20.50
Average Volume$388.42K
Market Capitalization$1.06B

ARQTShare Price Chart


Chart placeholderClick Calculate to get results

ARQTPerformance

The chart shows the growth of $10,000 invested in Arcutis Biotherapeutics, Inc. on Feb 3, 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $9,968 for a total return of roughly -0.32%. All prices are adjusted for splits and dividends.


ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

ARQTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M3.53%-6.21%
YTD4.77%-18.17%
6M8.11%-17.47%
1Y-20.66%-8.89%
5Y-0.13%8.23%
10Y-0.13%8.23%

ARQTMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ARQTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Arcutis Biotherapeutics, Inc. Sharpe ratio is -0.32. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

ARQTDividend History


Arcutis Biotherapeutics, Inc. doesn't pay dividends

ARQTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

ARQTWorst Drawdowns

The table below shows the maximum drawdowns of the Arcutis Biotherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Arcutis Biotherapeutics, Inc. is 61.11%, recorded on Jan 27, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-61.11%Feb 9, 2021245Jan 27, 2022
-51.71%Mar 24, 2020155Oct 30, 202067Feb 8, 2021222
-39.4%Mar 11, 20206Mar 18, 20202Mar 20, 20208
-6.89%Feb 27, 20202Feb 28, 20207Mar 10, 20209
-4.64%Feb 25, 20201Feb 25, 20201Feb 26, 20202
-3.77%Feb 11, 20205Feb 18, 20201Feb 19, 20206
-3.51%Feb 5, 20202Feb 6, 20201Feb 7, 20203

ARQTVolatility Chart

Current Arcutis Biotherapeutics, Inc. volatility is 77.05%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ARQT (Arcutis Biotherapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Arcutis Biotherapeutics, Inc.


Loading data...